| Prevention of HIV-1 infection with early antiretroviral therapy MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England journal of medicine 365 (6), 493-505, 2011 | 8803 | 2011 |
| Adherence to protease inhibitor therapy and outcomes in patients with HIV infection DL Paterson, S Swindells, J Mohr, M Brester, EN Vergis, C Squier, ... Annals of internal medicine 133 (1), 21-30, 2000 | 4515 | 2000 |
| Antiretroviral therapy for the prevention of HIV-1 transmission MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England Journal of Medicine 375 (9), 830-839, 2016 | 1850 | 2016 |
| Maraviroc for previously treated patients with R5 HIV-1 infection RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ... New England Journal of Medicine 359 (14), 1429-1441, 2008 | 913 | 2008 |
| Class-sparing regimens for initial treatment of HIV-1 infection SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ... New England Journal of Medicine 358 (20), 2095-2106, 2008 | 868 | 2008 |
| Timing of antiretroviral therapy for HIV-1 infection and tuberculosis DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ... New England Journal of Medicine 365 (16), 1482-1491, 2011 | 728 | 2011 |
| Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ... The Lancet infectious diseases 14 (4), 281-290, 2014 | 634 | 2014 |
| Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression S Swindells, JF Andrade-Villanueva, GJ Richmond, G Rizzardini, ... New England Journal of Medicine 382 (12), 1112-1123, 2020 | 403 | 2020 |
| Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness S Swindells, J Mohr, JC Justis, S Berman, C Squier, MM Wagener, ... International journal of STD & AIDS 10 (6), 383-391, 1999 | 394 | 1999 |
| Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin HA Gelbard, HS Nottet, S Swindells, M Jett, KA Dzenko, P Genis, R White, ... Journal of virology 68 (7), 4628-4635, 1994 | 389 | 1994 |
| Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. HS Nottet, Y Persidsky, VG Sasseville, AN Nukuna, P Bock, QH Zhai, ... Journal of immunology (Baltimore, Md.: 1950) 156 (3), 1284-1295, 1996 | 369 | 1996 |
| Four-month rifapentine regimens with or without moxifloxacin for tuberculosis SE Dorman, P Nahid, EV Kurbatova, PPJ Phillips, K Bryant, KE Dooley, ... New England Journal of Medicine 384 (18), 1705-1718, 2021 | 364 | 2021 |
| Adherence of human immunodeficiency virus—infected patients to antiretroviral therapy N Singh, SM Berman, S Swindells, JC Justis, JA Mohr, C Squier, ... Clinical infectious diseases 29 (4), 824-830, 1999 | 358 | 1999 |
| One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis S Swindells, R Ramchandani, A Gupta, CA Benson, J Leon-Cruz, ... New England Journal of Medicine 380 (11), 1001-1011, 2019 | 315 | 2019 |
| The neuropathogenesis of HIV-1 infection HE Gendelman, SA Lipton, M Tardieu, MI Bukrinsky, HSLM Nottet Journal of Leucocyte Biology 56 (3), 389-398, 1994 | 306 | 1994 |
| Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA AM Gross, PA Jaeger, JF Kreisberg, K Licon, KL Jepsen, M Khosroheidari, ... Molecular cell 62 (2), 157-168, 2016 | 296 | 2016 |
| Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non … ET Overton, G Richmond, G Rizzardini, H Jaeger, C Orrell, F Nagimova, ... The Lancet 396 (10267), 1994-2005, 2020 | 255 | 2020 |
| Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127 MG Peters, J Andersen, P Lynch, T Liu, B Alston‐Smith, CL Brosgart, ... Hepatology 44 (5), 1110-1116, 2006 | 249 | 2006 |
| Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy DA Wohl, G McComsey, P Tebas, TT Brown, MJ Glesby, D Reeds, ... Clinical Infectious Diseases 43 (5), 645-653, 2006 | 214 | 2006 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV 5 (5), e211-e220, 2018 | 213 | 2018 |
Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center在 unmc.edu 的电子邮件经过验证
